Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Polymorphisms in NRF2 and its target antioxidant genes: HMOX-1, NQO1, and MT, have been associated with cardiovascular diseases (CVDs) and diabetes in various ethnic groups, however, with variable results.
|
31332605 |
2020 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
The present study was conducted to investigate whether HO-1 plays a role in diabetes-induced vascular dysfunction.
|
31751579 |
2019 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Our data demonstrated that inducible nitric oxide synthase/gamma-Glutamyl-cysteine ligase (iNOS/GGCL) and DDAH dysregulation may play a key role in high glucose mediated oxidative stress, whereas HO-1 inducers such as CAPE or its more potent derivatives may be useful in diabetes and other stress-induced pathological conditions.
|
31108850 |
2019 |
Diabetes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Corrigendum to "Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients".
|
28642813 |
2019 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
These results suggest that RYR extract serves as alternative and complementary medicine in the treatment of these diseases, by inducing HO-1, thereby decreasing the vascular complications of diabetes.
|
28555162 |
2017 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
The effects of <i>Hmox1</i> haploinsufficiency were studied as a means of assessing the intrinsic contribution of HO-1 in the development of renal microvascular lesions during diabetes.
|
29359167 |
2017 |
Diabetes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Association of Nuclear Factor-Erythroid 2-Related Factor 2, Thioredoxin Interacting Protein, and Heme Oxygenase-1 Gene Polymorphisms with Diabetes and Obesity in Mexican Patients.
|
27274779 |
2016 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
HO-1 expression can be induced when glucose concentrations are above 25 mM; however, the role of HO-1 in lung cancer patients with diabetes remains unknown.
|
25661467 |
2015 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
We hypothesize that bilirubin mediates HO-1-induced vascular benefits in diabetes.
|
25475440 |
2015 |
Diabetes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The HO-1 risk polymorphism was more frequent in patients post-myocardial infarction (61.3% vs 32%; P=.0097), or with diabetes (68.4% vs 35.5%; P=.011) or a higher FRS (21.5 vs 15.7; P=.014).
|
23293173 |
2013 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
This review focuses on the role of HO-1 in angiogenesis and vasculogenesis, having a closer look at the significance of this system in diabetes.
|
20539916 |
2010 |
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Selective expression of HO-1 prevented TNF- and hyperglycemia-mediated superoxide (O2-) formation, DNA degeneration, and upregulation of caspase, but increased the expression of pAkt and Bcl-xL, proteins responsible for endothelial dysfunction in diabetes.
|
17883332 |
2007 |
Diabetes
|
0.100 |
Biomarker
|
disease |
BEFREE |
Upregulation of heme oxygenase 1 (HO-1) and peroxidase in the early development of diabetes produces a decrease in oxidative-mediated injury.
|
17513461 |
2007 |
Diabetes
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
We aimed to determine the length of (GT)(n) repeats in the HO1 gene promoter by using capillary electrophoresis and HO enzymatic activity in mononuclear cells (MNCs) from adult diabetes patients.
|
17991645 |
2007 |
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
In contrast, HO-1 gene expression was correlated negatively with p22phox, TBARS, PCO, HbA(1c) and diabetes duration.
|
16759310 |
2006 |
Diabetes
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Overexpression of human heme oxygenase-1 attenuates endothelial cell sloughing in experimental diabetes.
|
15284058 |
2004 |